EXACT Sciences Stock Price (NASDAQ:EXAS)

Add to My Stocks
$21.42 $0.26 (1.2%) EXAS stock closing price Feb 24, 2017 (Closing)
EXACT Sciences
24 FEB 2017
amigobulls logo
EXAS hand_up
EXAS vs S&P 500
Closing Price: Feb 24, 2017
$21.42 ( -1.2%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 273.79%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

EXACT Sciences Snapshot Video

14 5 2

EXAS Stock Details

Prev Close* : $21.68
Market Cap:
Day Low: $21.05
52 Week Low: $4.67
Open: $21.5
Volume: 1996755
Day High: $21.87
52 Week High: $23.68

Latest Stock Market News

Latest Articles

EXACT Sciences News - From Partners

EXAS Stockcharts

View EXAS PE ratio, PS ratio stocks charts and compare with peers.
EXAS Chart
Note: Compare EXACT Sciences stock price history with the index and industry peers.

EXACT Sciences Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

EXACT Sciences Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

EXAS Industry Peers

Company Price Change (%)
Juno Therapeutics (JUNO)21.440.68 (3.07%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Quest Diagnostics (DGX)97.311.7 (1.78%)
Transgenomic (TBIO)0.430.04 (10.26%)
Cancer Genetics (CGIX)2.450.05 (2%)
Invitae Corp (NVTA)10.110.04 (0.39%)
Ironwood Pharma (IRWD)16.420.39 (2.32%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

EXACT Sciences Financial Statements

income statement20152014201320122011
Net Sales Or Revenues39.43M1.79M4.14M4.14M4.16M
Net Income-157.8M-100.04M-46.51M-52.42M-28.67M
Total Operating Expense174M98M50.89M56.78M32.95M
view EXACT Sciences Corporation income statement
balance sheet20152014201320122011
Total Assets364.29M311.62M146.62M112.11M96.95M
Total Liabilities37.44M22.64M11.31M13.52M13.45M
Shareholders Equity326.85M288.98M135.31M98.59M83.49M
view EXACT Sciences Corporation balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-1.29M3.79M-1.19M4.24M0.22M
Net Cash From (Used By) Operating Activities-134.01M-80.91M-39.29M-44.15M-27.82M
Increase (Decrease) In Prop Plant And Equipment-20.08M-12.53M-9.28M-0.68M-2.11M
view EXACT Sciences Corporation cashflow statement

EXACT Sciences Corporation Stock News - Partner Headlines

EXACT Sciences Stock Message Board

As of last trading day, EXACT Sciences stock price was 21.42. EXACT Sciences market capitalization is 2.4B and it represents the total market value of EXAS stock. A value investor must look at the fundamentals of a stock, and perform EXACT Sciences valuation, even though in the short-term sentiment and current breaking news might affect EXACT Sciences stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that EXACT Sciences is worth a lot, it will most likely be reflected in an inflated EXACT Sciences stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1996755 EXAS shares were traded yesterday, and EXACT Sciences stock chart shows that the EXAS stock quote hit a day high of 21.87 and day low of 21.05. The board of directors decide what percentage of a company's earnings will be paid out as dividends. EXACT Sciences stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.